Surgery, Gastroenterology and Oncology
Vol. 21, No. 1, March 2016
Staging of the neuroblastomas by computed tomography and magnetic resonance imaging
Alexandra Cristina Nicolae, Ioana Gabriela Lupescu
REVIEW, March 2016
Article DOI: 10.21614/jtmr-21-1-67
Neuroblastoma is the most frequent solid extra-cranial malignant tumor in children. A proper staging of the disease allows the selection of the appropriate treatment, including the surgical approach.
The present review aims to discuss and illustrate the role of computed tomography (CT) and magnetic resonance (MRI) in the differential diagnosis of the retroperitoneal or mediastinal masses, prior discovered by ultrasound or X-ray examination.

Furthermore, it is discussed the role of CT and MRI for staging the patients with a histological proof of neuroblastoma. CT scan is very useful to detect and characterize the thoracic and abdominal tumors and organ metastases, with a special quality in detecting structural microcalcifications.
MRI is sensitive for cranio-spinal primary tumors, marrow-bone metastases and mediastinal or pelvic primary or secondary tumors.

In conclusion, CT and MRI imaging are mandatory diagnostic tools in staging neuroblastomas, finding the optimal moment for the surgical treatment and establish the risk categories of the children.

Full Text Sources: Download pdf
Abstract:   Abstract EN
Views: 2788


Watch Video Articles


For Authors



Journal Subscriptions

Current Issue

Dec 2025

Supplements

Instructions for authors
Online submission
Contact
ISSN: 2559 - 723X (print)

e-ISSN: 2601 - 1700 (online)

ISSN-L: 2559 - 723X

Journal Abbreviation: Surg. Gastroenterol. Oncol.

Surgery, Gastroenterology and Oncology (SGO) is indexed in:
  • SCOPUS
  • EBSCO
  • DOI/Crossref
  • Google Scholar
  • SCImago
  • Harvard Library
  • Open Academic Journals Index (OAJI)

Open Access Statement

Surgery, Gastroenterology and Oncology (SGO) is an open-access, peer-reviewed online journal published by Celsius Publishing House. The journal allows readers to read, download, copy, distribute, print, search, or link to the full text of its articles.

Journal Metrics

Time to first editorial decision: 25 days
Rejection rate: 61%
CiteScore: 0.2



Meetings and Courses in 2025
Meetings and Courses in 2024
Meetings and Courses in 2023
Meetings and Courses in 2022
Meetings and Courses in 2021
Meetings and Courses in 2020
Meetings and Courses in 2019
Verona expert meeting 2019

Creative Commons License
Surgery, Gastroenterology and Oncology applies the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits readers to copy and redistribute the material in any medium or format, remix, adapt, build upon the published works non-commercially, and license the derivative works on different terms, provided the original material is properly cited and the use is non-commercial. Please see: https://creativecommons.org/licenses/by-nc/4.0/
Publisher’s Note:
The opinions, statements, and data contained in article are solely those of the authors and not of Surgery, Gastroenterology and Oncology journal or the editors. Publisher and the editors disclaim responsibility for any damage resulting from any ideas, instructions, methods, or products referred to in the content.